Skip to main content
Journal cover image

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

Publication ,  Journal Article
Ambrosy, AP; Fonarow, GC; Butler, J; Chioncel, O; Greene, SJ; Vaduganathan, M; Nodari, S; Lam, CSP; Sato, N; Shah, AN; Gheorghiade, M
Published in: J Am Coll Cardiol
April 1, 2014

Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both the United States and Europe. Although the outcomes for ambulatory HF patients with a reduced ejection fraction (EF) have improved with the discovery of multiple evidence-based drug and device therapies, hospitalized heart failure (HHF) patients continue to experience unacceptably high post-discharge mortality and readmission rates that have not changed in the last 2 decades. In addition, the proportion of HHF patients classified as having a preserved EF continues to grow and may overtake HF with a reduced EF in the near future. However, the prognosis for HF with a preserved EF is similar and there are currently no available disease-modifying therapies. HHF registries have significantly improved our understanding of this clinical entity and remain an important source of data shaping both public policy and research efforts. The authors review global HHF registries to describe the patient characteristics, management, outcomes and their predictors, quality improvement initiatives, regional differences, and limitations of the available data. Moreover, based on the lessons learned, they also propose a roadmap for the design and conduct of future HHF registries.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

April 1, 2014

Volume

63

Issue

12

Start / End Page

1123 / 1133

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • United States
  • Stroke Volume
  • Sex Distribution
  • Registries
  • Quality Improvement
  • Natriuretic Peptides
  • Mineralocorticoid Receptor Antagonists
  • Male
  • Length of Stay
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ambrosy, A. P., Fonarow, G. C., Butler, J., Chioncel, O., Greene, S. J., Vaduganathan, M., … Gheorghiade, M. (2014). The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol, 63(12), 1123–1133. https://doi.org/10.1016/j.jacc.2013.11.053
Ambrosy, Andrew P., Gregg C. Fonarow, Javed Butler, Ovidiu Chioncel, Stephen J. Greene, Muthiah Vaduganathan, Savina Nodari, et al. “The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.J Am Coll Cardiol 63, no. 12 (April 1, 2014): 1123–33. https://doi.org/10.1016/j.jacc.2013.11.053.
Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014 Apr 1;63(12):1123–33.
Ambrosy, Andrew P., et al. “The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.J Am Coll Cardiol, vol. 63, no. 12, Apr. 2014, pp. 1123–33. Pubmed, doi:10.1016/j.jacc.2013.11.053.
Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014 Apr 1;63(12):1123–1133.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

April 1, 2014

Volume

63

Issue

12

Start / End Page

1123 / 1133

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • United States
  • Stroke Volume
  • Sex Distribution
  • Registries
  • Quality Improvement
  • Natriuretic Peptides
  • Mineralocorticoid Receptor Antagonists
  • Male
  • Length of Stay